EUVIMEDEUVIMED entdecken
Crossref

Genomic Benchmarking Reveals Reduced and Context-Dependent Transferability of AI-Engineered Bxb1 Recombinases for Large-Fragment Genome Writing

Yi-Dan Sun iD, Li-Jun Song iD, Bin Liu, Chong-Yan Cheng, Li-Ming Zhang, Jian-Ping Zhang, Xiao-Bing Zhang

The CRISPR Journal · 06.08.2026

DOI: 10.1177/25731599261470587 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The CRISPR Journal, online erschienen am 06.08.2026. Verfasst von Yi-Dan Sun und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute …. Die Arbeit nennt 29 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Programmable large-fragment genome integration using prime-editing-coupled serine integrases, such as PASTE and PASSIGE, remains constrained by the limited activity of wild-type Bxb1 (WT Bxb1) in mammalian cells. Recently, the AI-guided protein engineering framework EVOLVEpro enabled efficient identification of functional protein variants from limited experimental sampling and nominated epBxb1(T166R) as a highly active Bxb1 variant in episomal plasmid-to-plasmid recombination screens. Here, we systematically benchmarked epBxb1 (T166R) against WT Bxb1 and the previously validated high-activity eeBxb1 (V74A/E229K/V375I) variant in genome-integrated reporter and endogenous-locus PASSIGE assays at three well-characterized benchmarking loci ( AAVS1 , CCR5 , and ACTB ). epBxb1 showed reduced and variable transferability, with no detectable advantage over WT Bxb1 in the genome-integrated reporter system or at the AAVS1 safe-harbor locus, but produced modest, locus-dependent improvements at CCR5 and ACTB , with 1.89-fold and 1.58-fold increases, respectively. By contrast, eeBxb1 consistently showed superior activity, achieving up to ∼12-fold improvement over WT Bxb1. Four additional rounds of EVOLVEpro-guided optimization on the eeBxb1-BPNLS scaffold identified no reproducibly improved variant among 40 tested single-amino-acid substitutions. These results indicate reduced and genomic context-dependent transferability of EVOLVEpro-nominated Bxb1 variants and highlight the importance of application-matched genomic benchmarking when implementing AI-guided protein optimization for therapeutic genome writing.

Autor:innen und Institutionen

  • State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sc…
  • Tianjin Institutes of Health Science, Tianjin, China.
  • School of Life Sciences, Nankai University, Tianjin, China.

ORCID-Profile: Yi-Dan Sun, Li-Jun Song

Zitieren

APA

Sun, Y. D., Song, L. J., Liu, B., Cheng, C. Y., Zhang, L. M., Zhang, J. P., & Zhang, X. B. (2026). Genomic Benchmarking Reveals Reduced and Context-Dependent Transferability of AI-Engineered Bxb1 Recombinases for Large-Fragment Genome Writing. The CRISPR Journal. https://doi.org/10.1177/25731599261470587

Vancouver

Sun YD, Song LJ, Liu B, Cheng CY, Zhang LM, Zhang JP, et al. Genomic Benchmarking Reveals Reduced and Context-Dependent Transferability of AI-Engineered Bxb1 Recombinases for Large-Fragment Genome Writing. The CRISPR Journal. 2026. doi:10.1177/25731599261470587

BibTeX
@article{Sun2026,
  author = {Sun, Yi-Dan and Song, Li-Jun and Liu, Bin and Cheng, Chong-Yan and Zhang, Li-Ming and Zhang, Jian-Ping and Zhang, Xiao-Bing},
  title = {Genomic Benchmarking Reveals Reduced and Context-Dependent Transferability of AI-Engineered Bxb1 Recombinases for Large-Fragment Genome Writing},
  journal = {The CRISPR Journal},
  year = {2026},
  doi = {10.1177/25731599261470587}
}
Kostenlos starten →